Infliximab-induced acute hepatitis during Crohn's disease therapy: Absence of cross-toxicity with adalimumab;Hépatite aiguë à l'infliximab au cours du traitement d'une maladie de Crohn: Absence de toxicité croisée avec l'adalimumab

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 8-9, 2010, Pages e7-

  Haennig, A ^a   Bonnet, D ^a   Thebault, S ^a   Alric, L ^a,b  

^a CHU PURPAN   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; COLON ULCER; CROHN DISEASE; ECHOGRAPHY; ENTEROPATHY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INTESTINAL INTOLERANCE; LETTER; LIVER BIOPSY; MALE; MOUTH ULCER; NAUSEA; SIDE EFFECT;

EID: 77957017374     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.01.016     Document Type: Letter

References (5)

1. Garcia Aparicio A.M., Rey J.R., Hernandez Sanz A., Sampedro Alvarez J. Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab. Clin Rheumatol 2007, 26:811-813.
2. Thiéfin G., Morelet A., Heurgé A., Diebold M.D., Eschard J.P. Infliximab-induced hepatitis: absence of cross-toxicity with etanercept. Joint Bone Spine 2008, 75:737-739.
3. Becker H., Willeke P., Domschke W., Gaubitz M. Etanercept in a patient with previous infliximab-induced hepatitis. Clin Rheumatol 2008, 27:1597-1598.
4. Wahie S., Alexandroff A., Reynolds N.J. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis. Clin Exp Dermatol 2006, 31:460-461.
5. Massarotti M., Marasini B. Successful treatment with etanercept of a patient with psoriatic arthritis after adalimumab-related hepatotoxicity. Int J Immunopathol Pharmacol 2009, 22:547-549.